Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences


SafetyAlerts
December 21, 1999

AstraZeneca Warns of  Serious Adverse Effects During Off-Label Use of Streptase

Wilmington, DE (SafetyAlerts) - AstraZeneca has today released a letter to warn physicians and hospital pharmacies of   the occurrence of serious adverse events associated with an off-label use of Streptase┬« (streptokinase). 

Under postmarketing surveillance, AstraZeneca has received an increasing number of reports of adverse events associated with the use of STREPTASE to restore patency of intravenous catheters (including central venous catheters). The serious adverse events include hypotension, hypersensitivity reactions, apnea, and bleeding, some of which were life threatening.

While the events themselves are not inconsistent with those currently listed in the approved labeling, they represent an increase in frequency and appear to follow the reduced availability of Abbokinaseâ (urokinase).

STREPTASE is not indicated for restoration of patency of intravenous catheters. Most of the serious adverse events relating to the use of streptokinase in the restoration of patency of occluded intravenous catheters reported to AstraZeneca have involved the use of high doses of streptokinase in small volumes (250,000 IU in 2 mL). Uses of lower doses of streptokinase in infusions over several hours, generally into partially occluded catheters, or local instillation into the catheter lumen and subsequent aspiration, have been described in the medical literature.

The company is warning Health care providers to consider the risk for potentially life-threatening reactions associated with the use of streptokinase in the management of occluded intravenous catheters.

Adverse events possibly associated with the use of Streptase should be reported to the Information Center at AstraZeneca at 1-800-236-9933.  

Alternatively, this information may be reported to FDA’s MedWatch reporting system by phone (1-800-FDA-1088), facsimile (1-800-FDA-0178), the MedWatch website at www.fda.gov/medwatch, or mailed to MedWatch, HF-2, 5600 Fishers Lane, Rockville, MD 20852-9787.

Both health care professionals and consumers should use the Form 3500 for reporting adverse events.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

Top of Page
(To return - Click Back On Your Browser)